Literature DB >> 16340798

Detection of antibodies to HLA-DP in renal transplant recipients using single antigen beads.

Jianxin Qiu1, Junchao Cai, Paul I Terasaki, Nadim El-Awar, Jar-How Lee.   

Abstract

With the development of single DP-antigen beads, antibodies to DP could clearly be segregated from other HLA antibodies. We studied 323 sera of patients from four different centers with functioning or rejected kidney grafts. DP antibodies were found in 5.1% of 138 patients with functioning grafts, and 19.5 % of 185 patients with rejected grafts (P<0.001)). 42.9% and 63.9% of the DP antibody positive patients had DR/DQ antibodies among the functioning and rejected group. Among patients who did not have Class I and DR/DQ antibodies, 13% of those who rejected a graft had DP antibodies, compared to 3.5% of patients with functioning grafts (P<0.05). DP 0301 had the highest specificity frequency in the rejected group. In conclusion, HLA-DP antibodies were detected at a higher frequency in patients who have rejected their grafts than those with functioning grafts. For regrafts, DP tissue typing is recommended to avoid presensitized DP alleles.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16340798     DOI: 10.1097/01.tp.0000181384.49832.3a

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  11 in total

1.  HLAMatchmaker: a molecularly based algorithm for histocompatibility determination. V. Eplet matching for HLA-DR, HLA-DQ, and HLA-DP.

Authors:  Rene J Duquesnoy; Medhat Askar
Journal:  Hum Immunol       Date:  2006-10-30       Impact factor: 2.850

2.  Resolving MiSeq-Generated Ambiguities in HLA-DPB1 Typing by Using the Oxford Nanopore Technology.

Authors:  Jamie L Duke; Timothy L Mosbruger; Deborah Ferriola; Nilesh Chitnis; Taishan Hu; Nikolaos Tairis; David J Margolis; Dimitri S Monos
Journal:  J Mol Diagn       Date:  2019-06-04       Impact factor: 5.568

Review 3.  Anti-HLA antibody testing in hematology patients.

Authors:  Jeremy Ryan A Peña; Susan L Saidman
Journal:  Am J Hematol       Date:  2015-04       Impact factor: 10.047

Review 4.  Kidney transplantation in highly sensitized patients: are there options to overcome a positive crossmatch?

Authors:  Christian Morath; Jan Schmidt; Gerhard Opelz; Martin Zeier; Caner Süsal
Journal:  Langenbecks Arch Surg       Date:  2011-03-18       Impact factor: 3.445

Review 5.  Luminex and antibody detection in kidney transplantation.

Authors:  Antonietta Picascia; Teresa Infante; Claudio Napoli
Journal:  Clin Exp Nephrol       Date:  2012-05-03       Impact factor: 2.801

6.  Preformed donor HLA-DP-specific antibodies mediate acute and chronic antibody-mediated rejection following renal transplantation.

Authors:  E C Jolly; T Key; H Rasheed; H Morgan; A Butler; N Pritchard; C J Taylor; M R Clatworthy
Journal:  Am J Transplant       Date:  2012-07-03       Impact factor: 8.086

Review 7.  Emerging monitoring technologies in kidney transplantation.

Authors:  Abdulla Ehlayel; K'joy J A Simms; Isa F Ashoor
Journal:  Pediatr Nephrol       Date:  2021-02-01       Impact factor: 3.714

8.  Evaluation of the humoral immune response to human leukocyte antigens in Brazilian renal transplant candidates.

Authors:  Patricia Keiko Saito; Roger Haruki Yamakawa; Erica Pereira Aparecida; Waldir Verissimo da Silva Júnior; Sueli Donizete Borelli
Journal:  PLoS One       Date:  2014-06-13       Impact factor: 3.240

9.  Successful kidney transplantation after desensitization in a patient with positive flow crossmatching and donor-specific anti-HLA-DP antibody: A Case report.

Authors:  Seung Hwan Song; Borae G Park; Juhan Lee; Myoung Soo Kim; Yu Seun Kim; Hyon-Suk Kim
Journal:  Medicine (Baltimore)       Date:  2016-08       Impact factor: 1.889

Review 10.  Kidney Transplantation: The Challenge of Human Leukocyte Antigen and Its Therapeutic Strategies.

Authors:  Tilahun Alelign; Momina M Ahmed; Kidist Bobosha; Yewondwossen Tadesse; Rawleigh Howe; Beyene Petros
Journal:  J Immunol Res       Date:  2018-03-05       Impact factor: 4.818

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.